CIDRAP newsletters options
Vaccine contracts with both Moderna and Pfizer come ahead of booster dose campaigns expected to begin in September.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Jul 28
An analysis of urine specimens from male patients in Germany found high levels of antibiotic resistance in the most frequent causes of urinary tract infections (UTIs), researchers reported today in Eurosurveillance.
COVID-19 patients who have a stroke are more than twice as likely to die than uninfected stroke patients and are often younger and healthier, finds research presented yesterday at the Society of NeuroInterventional Surgery’s (SNIS's) 19th Annual Meeting in Toronto.
Environmental sampling indicates Burkholderia pseudomallei is endemic in the Gulf Coast region.
CDC today also provided a racial and symptom profile of US cases, which are quickly nearing 5,000 infections.
Though vaccine hesitancy plays a role, decreased access to vaccination sites may be another overlooked barrier, researchers suggest.
A systematic review and meta-analysis published yesterday in BMJ estimates that 5.6% of COVID-19 survivors may face long-lasting changes to their sense of smell or taste, adding to concerns about the overall burden of long COVID.
The head of the WHO today urged men who have sex with men to cut their risk by reducing their number of sexual partners and exposure to new partners.
As the pandemic worsened the opioid crisis, some states saw steeper methadone distribution declines than others, though it's not clear why.
Of hospitalized COVID patients, 53% still had brain fog 13 months later.
Studies suggest the market didn't just amplify virus spread, it was the early epicenter and site of SARS-CoV-2 emergence.
The AMR Register will enable companies to share surveillance and susceptibility data with researchers.
Completion of a primary COVID-19 vaccination series after recovery from infection was tied to half the risk of reinfection in the pre-Omicron variant era, according to a study published today in JAMA Network Open.
More broadly protective vaccines and ones that can block transmission and infection are among the next-generation vaccine goals.
The US total soars to nearly 3,500 cases, with all but 4 states now affected.
The risk of myocarditis and/or pericarditis was not significantly different among children ages 5 to 11 years after COVID-19 vaccination from that of unvaccinated children and much lower than that among children aged 12 to 17, finds a prospective study in Denmark published today in Pediatrics.
Paxlovid and molnupiravir stood out in a meta-analysis that compared the effectiveness of 16 different drug or drug combinations.
Recent cases in two US kids underscore close household contact as a transmission risk, as federal officials weigh declaring a national public health emergency.
Vaccines that are easier to administer, such as intranasal, and that provide broader protection are the main goals for future vaccines.
